Virpax Pharmaceuticals, Inc.

Ownership Transactions Reported by 17 Insiders

Symbol
VRPX on Nasdaq
Industry
Pharmaceutical Preparations
Location
1055 Westlakes Drive, Suite 300, Berwyn, Pennsylvania

There are no Buy or Sell transactions made by insiders since 9/12/2023

Virpax Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Jatinder Dhaliwal Director Jul 5, 2024
Gary Herman Director Jul 5, 2024
Katharyn Field Director Jul 5, 2024
Judy Su Director Jul 5, 2024
Vinay Shah Chief Financial Officer Jan 29, 2024
Michael F. Dubin Director Jan 29, 2024
Anthony P. Mack Chief Executive Officer, Director, 10%+ Owner Jan 25, 2023
Jerrold Sendrow Director Jan 29, 2024
Eric Floyd Director Jan 29, 2024
Thani Jambulingam Director Jan 29, 2024
Jeffrey Gudin Chief Medical Officer, Director Jan 25, 2023
Barbara Ruskin Director Jan 29, 2024
Gary Jacob Director Jan 1, 2022
Christopher Chipman Chief Financial Officer Jan 25, 2023
Gerald W. Bruce Chief Executive Officer, Director Jan 29, 2024
Vanila Singh Director Jan 29, 2024
Sheila Mathias Chief Scientific Officer Jan 29, 2024

Recent Insider Transactions by Companies or Individuals for Virpax Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.